The purpose of this Funding Opportunity Announcement (FOA) is to continue to increase the amount of publicly available, high-quality data describing structures and affinities of protein-drug ligand complexes -data vital for development, validation, and benchmarking of drug docking and screening software. Accurate and robust methods for in silico drug screening are expected to speed drug discovery and reduce drug development cost by focusing experimental efforts on the most promising candidate compounds. The ability to predict side effects resulting from off-target binding and to increase repurposing of existing pharmaceuticals is an additional expected benefit.
Only one application per institution (normally identified by having a unique DUNS number or NIH IPF number) is allowed.
Cooperative Agreement. NIGMS intends to fund 1 award, corresponding to approximately $750,000 for fiscal year 2014. Future year amounts will depend on annual appropriations. Application budgets may not exceed $500,000 direct costs per year. The project period is expected to be five years.
Admin/Reviewer Login here first
Back to the WINS main page